相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG
Jeong-Hee Kim et al.
SCHIZOPHRENIA RESEARCH (2017)
The Cattell-Horn-Carroll Model of Cognition for Clinical Assessment
Paul A. Jewsbury et al.
JOURNAL OF PSYCHOEDUCATIONAL ASSESSMENT (2017)
Construct Validity of Fluency and Implications for the Factorial Structure of Memory
Paul A. Jewsbury et al.
JOURNAL OF PSYCHOEDUCATIONAL ASSESSMENT (2017)
Risperidone improves interpersonal perception and executive function in patients with schizophrenia
Zhenhe Zhou et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
Hans Rasmussen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Anthony A. Grace
NATURE REVIEWS NEUROSCIENCE (2016)
Diffusion-weighted imaging uncovers likely sources of processing-speed deficits in schizophrenia
Peter Kochunov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Integrating the Switching, Inhibition, and Updating Model of Executive Function With the Cattell-Horn-Carroll Model
Paul A. Jewsbury et al.
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL (2016)
Improving clinical cognitive testing Report of the AAN Behavioral Neurology Section Workgroup
Kirk R. Daffner et al.
NEUROLOGY (2015)
GABAergic mechanisms of hippocampal hyperactivity in schizophrenia
Stephan Heckers et al.
SCHIZOPHRENIA RESEARCH (2015)
Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects
Anthony S. Gabay et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The Relationship between Processing Speed and Regional White Matter Volume in Healthy Young People
Daniele Magistro et al.
PLOS ONE (2015)
Neurocognition: Clinical and Functional Outcomes in Schizophrenia
Martin Lepage et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)
Glutamate-mediated excitotoxicity in schizophrenia: A review
Eric Plitman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E. M. P. Poels et al.
MOLECULAR PSYCHIATRY (2014)
Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies
Sudhakar Selvaraj et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
GABA and glutamate in schizophrenia: A 7 T H-1-MRS study
Anouk Marsman et al.
NEUROIMAGE-CLINICAL (2014)
Prefrontal Cortex Activity during Response Selection Predicts Processing Speed Impairment in Schizophrenia
Neil D. Woodward et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2013)
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
A. de Bartolomeis et al.
PSYCHOPHARMACOLOGY (2013)
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of H-1-MRS Studies
Anouk Marsman et al.
SCHIZOPHRENIA BULLETIN (2013)
Electrophysiological Evidence for Ventral Stream Deficits in Schizophrenia Patients
Gijs Plomp et al.
SCHIZOPHRENIA BULLETIN (2013)
IQ change over time in schizophrenia and healthy individuals: A meta-analysis
Anna M. Hedman et al.
SCHIZOPHRENIA RESEARCH (2013)
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Nina V. Kraguljac et al.
JAMA PSYCHIATRY (2013)
Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden
Helen Kitchen et al.
ADVANCES IN THERAPY (2012)
Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence
Mario Fioravanti et al.
BMC PSYCHIATRY (2012)
Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophrenia
Anthony A. Grace
NEUROPHARMACOLOGY (2012)
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial
A. P. Morrison et al.
PSYCHOLOGICAL MEDICINE (2012)
Attention in patients with chronic schizophrenia: Deficit in inhibitory control and positive symptoms
Flavia S. Galaverna et al.
EUROPEAN JOURNAL OF PSYCHIATRY (2012)
A new neural framework for visuospatial processing
D. Kravitz et al.
JOURNAL OF VISION (2011)
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Tyler A. Lesh et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Effects of quetiapine on executive functioning deficits in schizophrenia: short-term effect
Raul Mendoza Quinones et al.
SCHIZOPHRENIA RESEARCH (2011)
Processing Speed Deficits in Schizophrenia: Reexamining the Evidence
Emma E. M. Knowles et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Positron Emission Tomography in Schizophrenia: A New Perspective
Neva H. Patel et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Deconstructing processing speed deficits in schizophrenia: Application of a parametric digit symbol coding test
Peter Bachman et al.
SCHIZOPHRENIA RESEARCH (2010)
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia
Nicoletta M. J. van Veelen et al.
SCHIZOPHRENIA RESEARCH (2010)
Financial Exploitation and Psychological Mistreatment Among Older Adults: Differences Between African Americans and Non-African Americans in a Population-Based Survey
Scott R. Beach et al.
GERONTOLOGIST (2010)
A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents
Shane T. Harvey et al.
CLINICAL PSYCHOLOGY REVIEW (2010)
Neurocognition in First-Episode Schizophrenia: A Meta-Analytic Review
Raquelle I. Mesholam-Gately et al.
NEUROPSYCHOLOGY (2009)
The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response
Aygun Ertugrul et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Working memory in schizophrenia: a meta-analysis
N. F. Forbes et al.
PSYCHOLOGICAL MEDICINE (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Visual perception and its impairment in schizophrenia
Pamela D. Butler et al.
BIOLOGICAL PSYCHIATRY (2008)
The hippocampus and memory: insights from spatial processing
Chris M. Bird et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Cognitive processing speed and the structure of white matter pathways: Convergent evidence from normal variation and lesion studies
And U. Turken et al.
NEUROIMAGE (2008)
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment
Philip D. Harvey et al.
SCHIZOPHRENIA RESEARCH (2008)
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
Michael Riedel et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia
Ann M. Mortimer et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2007)
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect?
Terry E. Goldberg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review
A. D. Hutchinson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms
Michael Riedel et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
Psychomotor slowing in schizophrenia
Manuel Morrens et al.
SCHIZOPHRENIA BULLETIN (2007)
Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients
Shin-Min Lee et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Overlooking the obvious - A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia
Dwight Dickinson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels
Aygun Ertugrul et al.
PSYCHIATRY RESEARCH (2007)
Ziprasidone-induced cognitive enhancement in schizophrenia: Specificity or pseudospecificity?
Anil K. Malhotra et al.
SCHIZOPHRENIA RESEARCH (2006)
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine
Robert S. Kern et al.
PSYCHOPHARMACOLOGY (2006)
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine
S Bender et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer
A Stewart et al.
CLINICAL NEUROPSYCHOLOGIST (2006)
Trait vs. State Markers for Schizophrenia: Identification and Characterization Through Visual Processes
Yue Chen et al.
CURRENT PSYCHIATRY REVIEWS (2006)
Increased prefrontal and hippocampal glutamate concentration in schizophrenia:: Evidence from a magnetic resonance spectroscopy study
LT van Elst et al.
BIOLOGICAL PSYCHIATRY (2005)
Working memory impairments in schizophrenia: A meta-analysis
JH Lee et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2005)
The relationship of structural alterations to cognitive deficits in schizophrenia: A voxel-based morphometry study
E Antonova et al.
BIOLOGICAL PSYCHIATRY (2005)
Schizophrenia and the structure of language:: The linguist's view
MA Covington et al.
SCHIZOPHRENIA RESEARCH (2005)
A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia
M Fioravanti et al.
NEUROPSYCHOLOGY REVIEW (2005)
5-HT2A and muscarinic receptors in schizophrenia:: a postmortem study
I Matsumoto et al.
NEUROSCIENCE LETTERS (2005)
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism:: Randomized controlled trial of olanzapine vs amisulpride
M Wagner et al.
NEUROPSYCHOPHARMACOLOGY (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
PD Harvey et al.
PSYCHOPHARMACOLOGY (2004)
Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects
E Scarr et al.
SCHIZOPHRENIA RESEARCH (2004)
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol
RSE Keefe et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10 year longitudinal analysis
ES Herbener et al.
SCHIZOPHRENIA BULLETIN (2004)
Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature
C Anderson-Hanley et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2003)
Serotonin receptors : their key role in drugs to treat schizophrenia
HY Meltzer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia
A Abi-Dargham et al.
NEUROSCIENTIST (2003)
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study
PD Harvey et al.
PSYCHOPHARMACOLOGY (2003)
Impaired visual object recognition and Dorsal/Ventral stream interaction in schizophrenia
GM Doniger et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Aripiprazole: A third generation of Antipsychotics begins?
NL Keltner et al.
PERSPECTIVES IN PSYCHIATRIC CARE (2002)
The human hippocampus and spatial and episodic memory
N Burgess et al.
NEURON (2002)
Effects of newer Antipsychotics on extrapyramidal function
D Tarsy et al.
CNS DRUGS (2002)
Psychomotor slowing and planning deficits in schizophrenia
BJM Jogems-Kosterman et al.
SCHIZOPHRENIA RESEARCH (2001)
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
SE Purdon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
分享论文
